1131538

Repro Lab, Inc. — FEI 3000974212

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 16, 2020
Fiscal Year
2021
Product Type
Biologics
Project Area
Blood and Blood Products
Location
New York, NY (United States)

Citations

IDCFRDescription
1221321 CFR 1271.47(a)Testing, screening, donor eligibility procedures
1222921 CFR 1271.50(a)Determination based on screening and testing
1224121 CFR 1271.55(b)(4)Reasons for ineligibility on summary
1224721 CFR 1271.55(d)(2)Accurate, indelible, legible